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Summary
Tumor cells can evade chemotherapy by acquiring resistance to apoptosis. We investigated the molecular mechanism
whereby malignant and nonmalignant mammary epithelial cells become insensitive to apoptosis. We show that regardless
of growth status, formation of polarized, three-dimensional structures driven by basement membrane confers protection
to apoptosis in both nonmalignant and malignant mammary epithelial cells. By contrast, irrespective of their malignant
status, nonpolarized structures are sensitive to induction of apoptosis. Resistance to apoptosis requires ligation of 4
integrins, which regulates tissue polarity, hemidesmosome formation, and NFB activation. Expression of 4 integrin that
lacks the hemidesmosome targeting domain interferes with tissue polarity and NFB activation and permits apoptosis.
These results indicate that integrin-induced polarity may drive tumor cell resistance to apoptosis-inducing agents via
effects on NFB.
Introduction Rabinovitz and Mercurio, 1996). This paradox suggests that, in
some cases, ECM adhesion may foster tumor progression rather
Apoptosis is essential for immune surveillance and for the effi- than tumor inhibition (Tani et al., 1997; Pfohler et al., 1998).
cacy of tumor therapy (Costello et al., 1999; Rathmell and Interactions between tumor cell integrins and adhesion mole-
Thompson, 2002). Although considerable progress has been cules in the ECM microenvironment may drive the selection of
treatment-resistant tumors (Nicolson, 1988; Singh et al., 1997;made toward understanding how apoptosis is executed at the
cellular level (Adams and Cory, 1998; Thornberry and Lazebnik, Van Riet et al., 1998; Puduvalli, 2001). However, the rate at
which tumors can acquire resistance to treatment in vivo argues1998), less is known about what regulates apoptotic decisions
and how apoptotic agents could selectively target the tumor that mechanisms, functioning independently of genetic selec-
tion, must also operate to drive the genesis of apoptosis resis-tissues.
The site of tumor cell metastasis is influenced by the compo- tance in metastatic tumors.
The tissue ECM may modify the responsiveness of tumorssition of the extracellular matrix (ECM) and the integrins ex-
pressed by the tumor cells (Pignatelli and Stamp, 1995). Despite to exogenous apoptotic stimuli. Adhesion to ECM rapidly and
reversibly modifies the responsiveness of myeloma and lungthe fact that tumors overexpress ECM-degrading proteases,
aggressive tumors often make excess basement membrane tumor cells to chemotherapeutic drugs (Damiano et al., 1999;
Sethi et al., 1999). Tumor cells selected for their drug resistance(BM) and have abundant 4 integrins (Tagliabue et al., 1998;
S I G N I F I C A N C E
Here we used a 3D model of nonmalignant and malignant human breast epithelial cells that could be repeatedly and reversibly
organized into polarized tissue-like structures to study how normal tissues and some tumor cells resist apoptotic cell death by
chemotherapeutic agents and immune regulators. We show that, regardless of the genetic makeup, the rate of growth, or the
malignant status, resistance correlates with ECM composition, hemidesmosome-dependent polarity, and NFB activation. Our model
sheds light on the endogenous activation of this pathway in epithelial tissues. These data indicate the critical importance of tissue
architecture in resistance to apoptosis, have important implications for how tumor cells may become dormant, and offer possible
chemotherapeutic strategies.
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Figure 1. Only nonmalignant cells within mam-
mary acini are resistant to apoptosis
Apoptotic labeling indices calculated for S-1
and T4-2 cells treated with Trail peptide (1 g/
ml), anti-FAS mAb (IgM CH-11, 2 g/ml), TNF-
(100 nM), etoposide (50 M), cytochalasin B (1
M), or paclitaxol (120 nM). Cells were treated
(A) as monolayers on a thin coat of collagen I
for 24 hr or (B) as 3D structures in rBM for 96 hr.
Results are the mean  SEM of 3–5 separate ex-
periments, each with duplicates or triplicates.
in monolayer cultures develop changes in cell adhesion and emergence of multidrug-resistant tumors by influencing cell
death regulators through effects on cell adhesion-directed tis-integrin expression (Nista et al., 1997; Narita et al., 1998). Tumor
cells grown as three-dimensional (3D) multicellular spheroids sue architecture.
rapidly acquire and sustain a multidrug-resistant phenotype in
response to acute drug treatment (Durand and Olive, 2001; Results
Kerbel 1994), exhibit modified adhesion (Hauptmann et al.,
1995; St. Croix et al., 1998), and secrete ECM proteins (Santini Studies using cells in two-dimensional (2D) monolayers have
demonstrated clearly that deregulated expression of apoptosis-and Rainaldi, 1999). This implies that tissue organization, cell
adhesion, and the ECM may synergistically generate apoptosis mediating or -inhibiting molecules can confer resistances to
cytotoxic drugs and death receptor ligands (Kaufmann andresistance in metastatic tumors. We showed previously that
ECM-induced tissue architecture can override the proliferative Earnshaw, 2000; Zhang et al., 2000). Clinical studies in patients,
however, often have failed to verify these observations. In con-and invasive malignant phenotype, but that reversion is depen-
dent upon the 3D tissue microenvironment (Weaver et al., 1997; trast, excellent correlation is observed between resistances to
drugs in three-dimensional (3D) cultures of primary cancer cellsWang et al., 1998). Because reversion of the malignant pheno-
type and polarity are associated with recalcitrance to growth and immortalized malignant cells and tumors in vivo (Desoize
and Jardillier, 2000). Because we have observed previously thatfactor stimulation, we have now hypothesized that the ECM,
via cooperative interactions between integrins, the cytoskele- cells in 2D and 3D contexts integrate signaling pathways differ-
ently (Wang et al., 1998; Bissell et al., 1999; Bissell and Radisky,ton, and 3D tissue organization, dictates apoptosis inducibility
in mammary epithelial cells (MECs). 2001), we asked whether 3D tissue architecture could alter apo-
ptotic resistance to drugs, and if so, how? We therefore de-To show this, we used the HMT-3522 MEC model of breast
cancer progression (Briand et al., 1996; Weaver et al., 1996). signed experiments to investigate the link between cell adhesion
and 3D tissue architecture and the genesis of the apoptosis-This tumor cell series was established from a reduction mam-
moplasty of a woman with a nonmalignant breast lesion. Contin- resistant tumor phenotype.
ued passage and growth factor withdrawal led to the spontane-
ous generation of tumorigenic cells (Briand et al., 1996). We A differentiated tissue structure is resistant
to apoptosis inductionused the nonmalignant S-1 cells at passages 50–70 (“normal”;
S-1) and their tumorigenic progeny at passages 238–245 (T4-2). We asked whether interactions with BM modulate the sensitivity
of MECs to apoptotic stimuli in 3D cultures, and if malignantIn the present study we asked whether BM signaling via integrins
regulates apoptosis resistance in 3D structures of MECs, and transformation altered this responsiveness. We measured the
apoptotic sensitivity of S-1 and malignant T4-2 MECs to apo-if so, how. We determined that the BM component laminin can
drive resistance to apoptosis induced by immune modulators ptotic stimuli in 2D and 3D. S-1 and T4-2 MECs, grown as 2D
monolayers on a thin coat of collagen I, exhibited comparableand cytotoxic drugs by driving polarization via 64 integrin-
cytoskeletal interactions and NFB activation. Our data illustrate apoptotic responsiveness regardless of the kind of apoptotic
agent used. These included ligation of receptors for tumor ne-how the tissue microenvironment could rapidly influence the
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Figure 2. Polarized mammary structures are resis-
tant to apoptosis induction
S-1 acini produced within rBM were treated with
E-cadherin function-blocking mAb (HECD-1; 25
g/ml rBM) to perturb polarity. T4-2 structures
within rBM were treated with 1 integrin inhibitory
mAb (clone AIIB2; 1:50 ascites/ml rBM) to restore
polarity. A: Confocal microscopy of nuclei (pro-
pidium iodide), F-actin (FITC-phalloidin), -
catenin (Texas red), 4 integrin (Texas red), and
laminin-5 (FITC) fluorescence. Note that S-1 and
reverted T4-2 acini exhibit cortically organized
filamentous F-actin, cell-cell junction-localized
-catenin, basally localized 4 integrins, and
basally secreted laminin-5. Contrast with the S-1
disrupted and T4-2 disorganized structures. B:
Apoptotic labeling indices calculated for cells
grown as described in A, and treated with TNF-
(100 nM), etoposide (50 M), or anti-FAS mAb (2
g/ml) for 96 hr. Results are mean  SEM of 3–5
separate experiments, each with duplicates or
triplicates. C: BrdU labeling indices under condi-
tions described in B. Results are mean  SEM of
three separate experiments of 200–400 cells per
experiment. All cultures were analyzed after 10
days inside the rBM. Bar equals 10 m.
crosis factor (TNF-), Trail, Fas, or treatment with the microtu- to nonmalignant MEC acini; however, this mechanism was ab-
sent or was no longer functioning after malignant transformationbule reagent paclitaxol, the topoisomerase II inhibitor etoposide,
or the actin cytoskeletal disruptor cytochalasin B (Figure 1). (Figure 1B).
Nonmalignant MECs embedded in reconstituted BM (rBM)
formed growth-arrested 3D organoids (acini), whereas malig- A polarized mammary tissue structure is resistant
nant MECs continued to proliferate to form nonpolar, multicellu- to apoptosis induction
To determine whether the differential sensitivity in nonmalignantlar, and disorganized 3D aggregates (Petersen et al., 1992;
Weaver et al., 1997). The rBM conferred apoptosis resistance and malignant cells in 3D was a direct function of genetic
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Figure 3. The polarized acini resist apoptosis induction regardless of growth
status
A: Confocal microscopy of -catenin and collagen IV. Control S-1 structures
in rBM, S-1 in collagen I gels, and S-1 cells overexpressing EGF-R in rBM show
-catenin (Texas red) localized at cell-cell (adherens) junctions. However,
only the structures generated in the rBM acquired basal polarity as marked
by the basal deposition of collagen IV (Texas red). All cultures were analyzed
after 10 days in 3D gels. B: BrdU labeling indices for S-1 cells incorporated into
3D structures as described in A. Results are mean  SEM of three separate
experiments of 200–400 cells per experiment. C: S-1 cells propagated as
described in A were induced to undergo apoptosis by TNF- (100 nM),
etoposide (50 M), or anti-FAS mAb (2 g/ml) for 96 hr. Results are mean 
SEM of 3–5 separate experiments, each with duplicates or triplicates. Bar
equals 10 m.
Figure 4. BM-induced tissue polarity is necessary for apoptosis resistance
S-1 cells were grown either inside the rBM, inside collagen I, or inside collagen
I followed by addition of either rBM or laminin-1. A: Confocal microscopy
changes or whether it was the indirect result of the inability of of Z sections of nuclei (propidium iodide), -catenin (Texas red), 4 integrin
the T4-2 cells to form organized structures, we induced them (FITC), 6 integrin (FITC), and laminin-5 (FITC) fluorescence. All structures
had -catenin localized at cell-cell junctions. Although 3D structures grownto form polarized “reverted” structures (T4-Rvt), as described
in contact with collagen I had cytosolic 4 and 6 integrins and dispersedpreviously, by growing them within the rBM in the presence
laminin-5, when these cells were overlaid with rBM or laminin-1 (not shown),
of a function-blocking 1 integrin monoclonal antibody (mAb) their 4 and 6 integrins became reorganized to the site of cell-rBM interac-
(Weaver et al., 1997). T4-2 cells grown with the irrelevant anti- tions, and they assembled an endogenous BM as shown by deposition of
laminin-5 at the cell-rBM junction. B: Apoptotic labeling indices calculatedbody served as apoptosis-sensitive controls. Both S-1 acini
for S-1 cells grown as described in A. Cultures were treated with TNF- (100and T4-Rvt structures established tissue polarity as shown by
M) for 96 hr. Results are mean  SEM of 3–6 separate experiments, eachcortical actin, -catenin at cell-cell junctions, and secreted lami-
with duplicates or triplicates. Bar equals 10 m.
nin-5 and 4 integrin at their basal surface (Figure 2A) and
were resistant to apoptosis by all three apoptotic agents tested
(Figure 2B). Conversely, disruption of polarity by treating S-1
cells with a function-blocking anti-E-cadherin mAb (Figure 2A;
Day et al., 1999) inside the rBM resulted in clusters of cells
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with disordered filamentous actin, dispersed 4 integrin, and
intracellular and randomly secreted laminin-5, similar to the dis-
organized T4-2 colonies (Figure 2A). The disorganized S1 cells
now became very sensitive when the acinar polarity was com-
promised (Figure 2B).
BM-induced tissue polarity is necessary for apoptosis
resistance regardless of growth status
Cytotoxic drugs induce apoptosis in target cells based upon
their capacity to promote cell-cycle arrest (Roninson et al., 2001;
Hurley, 2002). Because the formation of tissue polarity and apo-
ptosis resistance was also associated with a substantial reduc-
tion in cell growth (Figure 2C), we asked whether growth arrest
was sufficient for apoptosis resistance. S1 cells form polarized,
growth-arrested structures within 3D rBM, whereas they growth
arrest within 3D collagen I gels but are not polarized (Lelievre
et al., 1998; Gudjonsson et al., 2002). In addition, S-1 cells that
overexpress EGF-R (Wang et al., 1998) continue to proliferate
but maintain basal polarity within rBM (Figure 3A). All three
groups maintain adherens junctions as shown by -catenin lo-
calized at cell-cell junctions (Figure 3A). A comparison of apo-
ptotic response indicated that only those MECs that were bas-
ally polarized, as indicated by deposition of an endogenous BM
(Figure 3A), were resistant to apoptosis following treatment with
TNF-, Fas mAb, or etoposide, whether growth-arrested or pro-
liferating (Figures 3B and 3C). In contrast, growth-arrested but
nonpolarized S-1 cells underwent apoptosis.
To investigate whether it is the presence of rBM molecules
per se or whether rBM-induced polarity is required for protec-
tion, we grew S-1 cells as 3D nonpolar spheroids within collagen
I gels or as 3D polar acini in rBM. In parallel, we liberated some
MEC 3D spheroids by collagenase treatment, suspended them
in polyHEMA-coated dishes, and then overlaid them with serum-
free medium supplemented with either BSA or rBM proteins.
All of these tissue structures were growth arrested (see Figure
3B) and showed adherens junctions as assessed by -catenin
(Figure 4A). Apoptosis could be readily induced in the S-1 non-
polar spheroids in collagen I gels, but once exposed to rBM,
they resembled polarized S-1 acini with basally localized 4
and 6 integrins and laminin-5, and they acquired apoptosis
resistance (Figure 4B). Figure 5. BM-induced tissue polarity regulates NFB activation and drives
Addition of laminin-1, the main component of the rBM, to apoptosis resistance in acini
3D collagen gels was shown previously to restore polarity to A: Confocal microscopy of cytokeratin 18 and NFB p65. Control S-1 acini
in rBM treated for 1 hr with TNF- (100 nM), Trail peptide (1 g/ml), or etopo-luminal breast epithelial cells (Gudjonsson et al., 2002).
side (50M) show cytoplasmic (cytokeratin 18; FITC) to nuclear translocationLaminin-1 was also sufficient for inhibiting apoptosis sensitivity
of NFB p65 (Texas red), whereas acini treated with C2-ceramide (5 M)in our experiments (Figure 4B). These results demonstrate that
do not. B: Cell viability calculated for control S-1 cells or S-1 cells expressing
tissue polarity, resulting from interaction with BM laminins, but a proteolytically resistant mutant IB grown in rBM to form acini and then
not other ECM molecules such as collagen I, is necessary and treated as described in A in the presence or absence of the multicatalytic
proteosome inhibitor MG 132 (5M). Results are mean SEM of 3–4 separatesufficient for protection from apoptosis induction.
experiments with 200–600 cells scored in each.
BM-induced tissue polarity regulates NFB activation
to drive apoptosis resistance
NFB is activated early during neoplastic transformation of the expression and stability of apoptosis regulators (Tanaka et al.,
mammary gland in rodents (Kim et al., 2000) and may play an 2000; Tergaonkar et al., 2002). Accordingly, we investigated the
important role also in the pathogenesis (Sovak et al., 1997) and relationship of NFB p65 activation to BM-induced polarity and
metastasis of human breast cancers (Nakshatri et al., 1997). apoptosis resistance. Within 1 hr of treatment of polarized S-1
Activated NFB is linked to repression of apoptosis during mam- acini with TNF-, Trail, or etoposide, nuclear localization of
mary involution in mice and increased survival of murine mam- NFB B p65 increased measurably (Figure 5A). When we used
mary epithelial cells in culture (Clarkson et al., 2000). NFB the multicatalytic proteasome inhibitor MG 132 or expressed a
activation also drives resistance to chemo- and radiation ther- mutant IB, which is resistant to proteolytic degradation, nu-
clear translocation of p65 did not occur (data not shown) and allapy (Baldwin, 2001; Baeuerle and Baltimore, 1996) and modifies
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Figure 6. 64 integrin directs apoptosis resis-
tance in 3D mammary organoids
A: Apoptotic labeling indices calculated for S-1
cells grown in collagen I and preincubated with
function-blocking mAb against 3 integrin
(clone P15B), 1 integrin (clone AIIB2), 6 integrin
(clone GoH3), 4 integrin (clone ASC 3), or an
isotype-specific IgG control for 30 min, overlaid
with rBM and then treated in suspension culture
with TNF- (100 M) for 96 hr. Results are the
mean  SEM of 4–8 separate experiments, all in
triplicate. B: Apoptotic labeling indices calcu-
lated for S-1 cells grown in collagen I gels follow-
ing ligation and clustering of 1 or 4 integrin or
a MHC cell surface molecule for 1 hr and then
treated with Trail (1 g/ml) for 96 hr. Results are
the mean  SEM of 2–6 separate experiments,
each with duplicates. C: Apoptotic labeling indi-
ces calculated for S-1 vector or tailless 4 integ-
rin-expressing cells grown in rBM for 10 days and
treatment with etoposide (50 M), Fas mAb (1
g/ml), or Trail (1 g/ml) for 96 hr. Results are the
mean  SEM of three separate experiments. D:
Immunofluoresence of HD-1, BP180, 6 integrin,
4 integrin, collagen IV, and laminin-5 (Texas red)
in S-1 control versus S-1 expressing tailless 4 in-
tegrin (GFP). Bar equals 10 M.
three of these agents induced apoptosis (Figure 5B). In contrast, apoptosis-sensitive S-1 spheroids isolated from collagen I gels
with function-blocking mAb to 2, 3, 6, 1, or 4 integrinceramide, which fails to induce nuclear translocation of NFB,
induced death in S-1 acini under all conditions (Figures 5A and 5B). or control IgG. The structures were suspended in polyHEMA-
coated dishes in serum-free media supplemented with eitherThese data show that BM-induced polarity modulates endogenous
NFB activation in epithelial acini and is one mechanism mediating BSA or rBM. The spheroids treated with rBM, but not BSA, that
were challenged with TNF- in the presence of mAb directedBM-induced apoptosis resistance in MEC acini.
against 1, 2, or 3 integrins were viable and intact, even after
96 hr of incubation (Figure 6A), and showed nuclear transloca-64 integrin directs apoptosis resistance
in 3D mammary organoids tion of NFB (data not shown). In contrast, cells in the rBM-
treated spheroids incubated with blocking mAbs to 6 or 4To address which laminin receptor is necessary for induction
of polarity and apoptosis resistance, we incubated nonpolar, integrins failed to establish polarity, did not activate NFB (data
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not shown), and showed significantly increased apoptosis when
challenged with TNF- for 96 hr (Figure 6A). Because S-1 MECs
do not express 61 integrin (data not shown), these results
indicate that 64 integrins, but not 21 or 31 integrins,
participate in regulating BM-directed apoptosis resistance in
polarized acini.
To establish whether ligation of 4 integrins was sufficient
to protect the nonpolarized spheroids from apoptosis induction,
we ligated and clustered their 1 or 4 integrins or MHC mole-
cules with mAbs that were crosslinked to magnetic beads. The
integrin-activated 3D MEC structures were suspended in poly-
HEMA-coated dishes in serum-free medium. mAb-bead-medi-
ated ligation of 4, but not 1 integrins, protected the MEC
spheroids from apoptosis induction (Figure 6B). Conversely,
when S-1 cells expressing a GFP-labeled tailless 4 integrin
were embedded in rBM to form growth-arrested structures,
NFB did not translocate to the nucleus following drug treatment
(data not shown) and cells did not develop polarity (Figure 6D).
These structures showed disrupted hemidesmosome forma-
tion, as indicated by randomly dispersed type 1 hemidesmo-
some protein, HD-1, and bullous pemphigoid antigen 180
(BP180; Figure 6D). Loss of tissue polarity and NFB activation
in these growth-arrested structures was associated with en-
hanced sensitivity to apoptosis induced by etoposide, Trail, and
Fas receptor ligation (Figure 6C). Thus, the ability of 4 integrins
to drive tissue polarity is essential for activation of NFB and
apoptosis resistance.
Disrupting hemidesmosome formation perturbs BM-
directed tissue polarity, inhibits NFB activation, and
permits induction of apoptosis in 3D acini
An important function of 4 integrin is to functionally link the
cytoskeleton to hemidesmosomes. Accordingly, we investi-
gated the role played by hemidesmosomes in induction of polar-
ity, NFB activation, and apoptosis resistance in MEC acini.
T4-2 nonpolar spheroids in rBM had sparsely dispersed hemi-
desmosomes (1 hemidesmosome/2 m plasma membrane), of
which90% were immature type II hemidesmosomes, disorga-
nized 4 integrin, a sparse random distribution of HD-1, and
predominantly cytosolic NFB p65 (Figure 7). In contrast, T4-2
cells in rBM, treated with a function-blocking 1 integrin mAb
but not nonspecific rat IgGs, reverted to polarized acini (Figure
7; see also Figure 2A). The polarized, reverted T4 structures
had basally organized4 integrin and HD-1, increased hemides-
mosomes (2 hemidesmosomes/3 m plasma membrane) of
which60% were mature type I hemidesmosomes and nuclear Figure 7. Apoptosis resistance in reverted tumor cells is associated with in-
localization of NFB p65 (Figure 7). These observations estab- creased levels of mature hemidesmosomes and constitutive activation of
NFBlish an association between 4 integrin-directed tissue polarity,
hemidesmosomes, and BM-induced apoptosis resistance. T4-2 cells were grown inside rBM with control mAb or were reverted with 1
integrin inhibitory mAb (AIIB2) and were analyzed after 12 days by transmis-Several amino acid residues in the connecting segment that
sion electron microscopy (TEM) and immunofluorescence. Both structuresresides between the four type-III fibronectin-like modules, to-
expressed the hemidesmosome proteins 4 integrin and HD-1 and con-ward the C terminus, are critical for targeting 4 integrin to tained hemidesmosomes; note, however, they are less abundant in the
hemidesmosomes (Figure 8A). To test the involvement of hemi- T4-2 control spheroids (1/2 m plasma membrane), and of these, 90% are
immature type II structures. Hemidesmosomes are more abundant in thedesmosomes, S-1 cells were transfected with one of the follow-
T4-revertants (Rvts), and 60% are of mature type I and are assembled ating: an untagged or RFP- or EGFP-tagged 4 integrin deleted
the basal tissue domain where 4 integrin and HD-1 are located. Hemides-in the cytoplasmic tail connecting segment (1314-1486), or
mosome formation in the T4-Rvts is associated with constitutively localized
wild-type 4 integrin, or vector control RFP- or EGFP-tagged NFB p65. Bars equal TEM 50 nm; confocal 10 M.
or untagged constructs. Pooled stable populations of S-1 cells
transfected with the connecting segment deleted 4 or wild-
type 4 integrin showed uniform expression of tagged RFP
protein (Figure 8C) and increased total 4 integrin expression
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Figure 8. Disrupting hemidesmosome formation perturbs BM-directed tissue polarity, inhibits NFB activation, and permits induction of apoptosis in 3D acini
A: Diagram of 4 integrin showing the hemidesmosome targeting domain in the cytoplasmic tail of the 4 integrin protein and the RFP tag. B: Western
blot of RIPA lysates of S-1 cells showing that the deleted and wild-type 4 integrin transfectants expressed elevated total levels of 4 integrin protein relative
to the vector controls. C: Phase contrast and immunofluorescence of 4 integrin deleted, wild-type, and vector control RFP-expressing S-1 cells in 2D. D:
Immunofluorescence of NFB p65 (Texas red) in S-1 cells in rBM expressing EGFP-tagged mutant 4 integrin and EGFP vector controls before and after 1
hr of TNF- treatment (100 M) showing reduced cytoplasmic to nuclear translocation of NFB p65 (Texas red) in mutant 4 integrin expressing S-1 cells. E:
Immunofluorescence of HD-1 (FITC), BP180 (FITC), -catenin (Texas red), 4 integrin (Texas red), and laminin-5 (FITC) fluorescence in S-1 cells in rBM expressing
mutant and wild-type 4 integrins and vector controls. 3D cultures were analyzed after 12 days inside rBM. Bar equals 10 m. F: Apoptotic labeling indices
calculated after 12 days cultivation in the rBM and treatment for 96 hr with TNF- (100 M), FAS receptor mAb (2 g/ml), or etoposide (50 M). Results are
the mean  SEM of three separate experiments.
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compared to S-1 vector controls (Figure 8B). All cells in 3D to most receptor-linked and many chemical stimuli. This pheno-
type requires 4 integrin to mediate hemidesmosome formationrBM assembled adherens junctions judged by localization of
-catenin (Figure 8E). Expression of the 4 integrin with the and to facilitate NFB activation. In support of these results, 4
integrin null keratinocytes exhibit reduced viability in responseconnecting segment deleted should act as a dominant negative
by competing with the endogenous, wild-type 4 integrin to to an exogenous mechanical stress in vivo (Dowling et al., 1996),
and targeted disruption of the LAMA3 gene in mice compro-disturb hemidesmosome organization and perturb cytoskeletal
organization. S-1 cells transfected with mutant 4 integrin con- mises keratinocyte survival (Ryan et al., 1999). Similarly, 1 and
4 integrins activate NFB to maintain survival during T cellsistently formed structures with dispersed, faint HD-1; with
patchy, sparsely distributed BP180; with cytosolic, nonpolarized development (Fiorini et al., 2000; Scupoli et al., 2000).
But how do tumor cells evade apoptotic therapy and what4 integrin; and with randomly secreted laminin-5, indicating
that disrupting hemidesmosome-cytoskeletal structures per- is the link to polarity? Our data suggest that epithelial tumors
that express4 integrins have the potential to acquire resistanceturbed polarity (Figure 8E). In contrast, vector control or S-1
cells infected with wild-type 4 integrin were polarized with to exogenous death stimuli if they are given the appropriate
spatial and biochemical cues from the microenvironment. Theintense staining for HD-1 protein and punctate basal BP180
(Figure 8E). Moreover, perturbing hemidesmosome organization T4-2 breast tumor cells express 4 integrin and are sensitive
to induction of apoptosis when they are grown in both two-in the 3D MEC structures with mutant EGFP-tagged 4 integrin
reduced NFB activation and led to a significant enhancement dimensional and three-dimensional cultures. However, they ac-
quire an apoptosis-resistant phenotype when they recapitulatein apoptosis sensitivity (Figures 8D and 8F). These observations
establish that ligation of 64 integrins, formation of mature a three-dimensional, polarized architecture accompanied with
endogenously activated NFB p65. These findings provide ahemidesmosomes, and activation of NFB p65 are linked to
BM-directed tissue polarity and resistance to apoptosis. rationale for a number of previous reports in the literature. Ag-
gressive and metastatic breast tumor cell lines express4 integ-
rins (Taylor-Papadimitriou et al., 1993; Jones et al., 1997). Fur-Discussion
thermore, the highly metastatic, 64 integrin-positive breast
epithelial cell line MDA MB-231 rapidly and reversibly acquiresThese studies emphasize the important contribution of the tis-
sue microenvironment and tissue architecture both in the media- a multidrug apoptosis-resistant phenotype when grown in three
tion of normal breast tissue viability as well as in the generation dimensions (Graham et al., 1994; Kerbel et al., 1996; St. Croix
of the apoptosis-resistant phenotype of breast tumors. Our data et al., 1998). The data are also consistent with clinical reports
stress the relevance of recapitulating cellular context when at- that individuals expressing both BM proteins and 4 integrins in
tempting to delineate the mechanisms underlying cell behavior. their primary tumors have the poorest prognosis among breast
By taking advantage of the mammary epithelial tumor progres- cancer patients (Tagliabue et al., 1998) and that breast tumors
sion model, HMT-3522, and 3D assays in rBM or collagen-I gels, frequently show increased expression of NFB-regulated genes
we were able to determine how nonmalignant and tumorigenic such as survivin (Tanaka et al., 2000). A recent study showed
breast epithelial cells could become resistant to apoptosis. The that more than 60% of primary breast tumor tissues express
studies described here show that tissue architecture regulates high levels of both 4 integrin and laminin-5 (Davis et al., 2001)
sensitivity to exogenous apoptotic stimuli and that this effect and more than 50% of dormant, metastatic cells isolated from
is mediated via integrin-cytoskeletal associations and activation the bone marrow of breast cancer patients express 6 and/or
of NFB. Laminin-induced ligation of 4 integrin directs tissue 4 integrins (Putz et al., 1999). Furthermore, deregulated NFB
polarity and promotes resistance to apoptosis in both nonmalig- has been implicated as an important prognostic indicator in
nant and malignant breast epithelial structures, regardless of primary and metastatic breast tumors (Nakshatri et al., 1997;
growth status. The apoptosis resistance depends upon the 3D Sovak et al., 1997; Kim et al., 2000), underscoring the potential
organization of the acini and is functionally linked to 4 integrin- relevance of our present studies to tumor pathology.
directed hemidesmosome formation and NFB activation. Thus, Our model suggests that integrin-directed tumor architec-
integrin-laminin interactions not only initiate signals essential ture may constitute a prognostic indicator of future tumor behav-
for cell growth, viability, and functional differentiation (Streuli et ior and apoptosis sensitivity. The major event regulating tumor
al., 1991; Boudreau et al., 1995; Howlett et al., 1995), but also metastasis is survival of the tumor cell in the distant site (Wong
protect mammary cells that are organized into tissue-like struc- et al., 2001). Accordingly, our data may explain why tumors
tures from exogenous apoptotic cues. The unit structure of the preferentially colonize selected tissues. In addition to providing
tissue thus emerges as an important determinant of normal the soluble factors and blood flow dynamics deemed necessary
tissue homeostasis (Bissell et al., 1999). for promoting the dissemination of metastatic tumor cells (Taylor
The presence of hemidesmosomes in epithelial tissues sta- et al., 2000), viable sites for tumor metastasis may also provide
bilizes attachments to the underlying BM (Jones et al., 1998). the appropriate ECM, microenvironmental, and spatial informa-
64 integrins play a diverse role in normal epithelial physiology tion critical for tumor cell survival.
(Borradori and Sonnenberg, 1999) by acting as laminin receptors
Experimental proceduresthat interact with intermediate filaments via long cytoplasmic
tails (Spinardi et al., 1995). This facilitates branching morpho-
Substrates and antibodiesgenesis (Stahl et al., 1997), cell proliferation (Mainiero et al.,
The material used were as follows: commercial EHS matrix (Matrigel, Col-1997), and migration (Goldfinger et al., 1999). Here we show
laborative Research) for the rBM assays; Vitrogen (Vitrogen 100, Celtrix
that ligand-activated 4 integrin is involved directly in induction Laboratories; bovine skin collagen I), 3 mg/ml, for coating culture dishes;
of tissue polarity in mammary epithelial acini and in modulating Cellagen Solution AC-5, 0.5% (ICN Biomedical, Inc.) for the 3D collagen I
assays; and poly HEMA, 6 mg/ml (Sigma Chemicals) for the cell suspensiona program that leads to the acquisition of apoptosis resistance
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studies. Antibodies used were: collagen IV, clone PHM-12 (Biogenex); lami- be inhibited by prior treatment with the caspase inhibitors YVAD-CHO or
nin-5 3 chain specific, clone BM165 (gift of M.P. Marinkovich, Stanford; DEVD-CHO (1 M; BioMol Research Laboratories Inc.).
Rousselle et al., 1991); 6 integrin, clones J15B (gift of C. Damsky, UCSF)
and GoH3 (Chemicon International); 2 integrin, clone 10G11, and 3 integ- BM overlay assay and integrin inhibition studies
rin, clone P15B (Chemicon International); 1 integrin, clones AIIB2 (gift of To assay for effects of rBM overlay on multicellular structures, cells were
C. Damsky, UCSF) and TS2-16 (gift of M. Hemler, Harvard); 4 integrin, grown in collagen I gels to form spheroids, growth-arrested by removal of
rabbit sera, and clones 3E1, ASC-3, and ASC-8 (Chemicon International); EGF for 24 hr, collagenase-liberated, and suspended in polyHEMA-coated
BP180, rabbit sera J17 (J. Jones, Northwestern); HD-1, clone 121 (gift of K. dishes in H14 media supplemented with either BSA or rBM proteins (2
Owaribe, Graduate School of Human Informatics, Okazaki, Japan; Okumura mg/ml). To inhibit integrin function, the 3D multicellular structures were
et al., 1999); -catenin, clone 14 (Transduction Laboratories); FAS receptor, preincubated with 2 integrin (4–16 g IgG/ml); 3 integrin (1:25–1:100
clones IgM CH-11 (MBL Co., Ltd.) and CD95 (Immunotech, Inc.); E-cadherin ascites/ml); 6 integrin (4–12 g IgG/ml); 1 integrin (1:25–1:100 ascites/ml);
clone HECD-1 (Zymed); NFB p65, rabbit sera (Santa Cruz); cytokeratin 18, 4 integrin (4–16 g IgG/ml); or IgG isotype matched control mAb (4–16 g
clone RCK106 (Transduction Laboratories); human MHC class I clone W6.32 IgG/ml).
(Sigma); and actin, FITC-conjugated Phalloidin (Molecular Probes), fluores-
cein- and Texas red-conjugated, nonconjugated anti-mouse and anti-rat, Antibody-conjugated beads and integrin activation studies
and nonspecific rat and mouse IgGs (Jackson Laboratories). The multicata- Monoclonal anti-human 1-integrin (TS2-16), 4-integrin (3E1), human MHC
lytic proteosome inhibitor MG132 (5 mM stock in DMSO; Calbiochem) was class I (W6.32), or nonspecific IgG control mAb was covalently attached to
used at 0.5–5.0 M. magnetic porous glass beads (5 M) by hydrazide crosslinking (CPG Inc.).
Briefly, IgG protein was diluted (200 g/ml; 100 g total IgG), dialyzed
Cell culture overnight in oxidation buffer (100 mM sodium acetate, 150 mM sodium
The HMT-3522 MECs were grown and manipulated in 2D and 3D as de- chloride [pH 5.5]), and then activated by periodate treatment (10 mM sodium
scribed (Petersen et al., 1992; Weaver et al., 1997). Phenotypic reversion of periodate). After quenching (50% glycerol), mAb was dialyzed into coupling
T4-2 cells, using 1 integrin function-blocking mAb, and disruption of S-1 buffer (100 mM sodium acetate, 150 mM sodium chloride [pH 4.5]) and
morphogenesis, using the E-cadherin function-blocking mAb, were exactly linked to prewashed MPG hydrazide beads, capped (67 mM glyceraldehyde,
as described (Weaver et al., 1997; Wang et al., 1998). in coupling buffer), washed, and stored in buffer (PBS: 138 mM sodium
chloride, 2.7 mM potassium chloride, 8.1 mM disodium phosphate, 1.2 mM
Indirect immunofluorescence analysis and image acquisition potassium phosphate, 0.5 mM magnesium chloride, 0.1% Tween 20). To
Cells were either directly fixed using 2% paraformaldehyde or in 1:1 metha- monitor for apoptosis resistance induced by integrin activation in 3D sphe-
nol:acetone or 100% methanol, or first extracted in situ using CSK buffer roids, prewashed (10  DMEM:F12) mAb crosslinked beads (1 g IgG/2 
(50 mM HEPES, 300 mM sucrose, 100 mM KCl, 5 mM MgCl, 5 mM EDTA, 105 beads/105 cells) were preincubated with suspensions of collagenase-
0.5% Triton X-100, containing 10 g/ml leupeptin, 10 g/ml pepstatin, 1 mM liberated 3D collagen I structures followed by incubation with the apoptosis-
Pefabloc [Boehringer Mannheim], 10 g/ml E64, 25 g/ml aprotinin, 0.5 mM inducing agent.
benzamidine, 1 mM sodium orthovanadate, and 20 mM sodium fluoride)
and subsequently fixed. In some experiments, cultures were embedded in
Electron microscopy analysis
sucrose and frozen in Tissue-Tek OCT compound (Miles Laboratories), and
Cells in rBM were fixed for a minimum of 30 min (2% glutaraldehye in 0.1
5 m frozen sections were prepared for immunostaining. Cell samples were
M sodium cacodylate buffer [pH 7.2]), washed three times in 0.1 M sodium
incubated with primary mAbs followed directly by either FITC- or Texas red-
cacodylate buffer, postfixed (1% OsO4 containing 0.8% potassium ferricya-conjugated secondary Abs. Nuclei were counterstained with diaminophenyl-
nide), stained with uranyl acetate, dehydrated in ethanol, and embedded in
indole (DAPI, Sigma) or propidium iodide (Sigma). Cells were visualized using
Epon-Araldite resin (Tousimis Corp.). Thin sections of embedded material
a Bio-Rad MRC 1024 laser scanning confocal microscope attached to a
were stained with lead nitrate and sodium citrate and viewed at 60 kV in aNikon Diaphot 200 microscope. All immunofluorescence images were re-
JEOL 100CX electron microscope (JEOL USA).corded at 120 magnification.
Preparation of MECs expressing mutant 4 integrinAnalysis of cell growth
and the IB mutantThe proliferation rate of cells was measured by assaying BrdU incorporation
S-1 nonmalignant HMT-3522 cells were transfected with mutant 4 integrinusing a commercially available labeling and detection kit (Boehringer Mann-
connecting segment deleted and pcDNA 3.1 plasmid DNA using LipofectAM-heim). The BrdU-labeling index was determined by scoring the BrdU-positive
INE (GIBCO-BRL) or infected with GFP-tagged tailless 4 integrin or RFP-cells and expressing this as a percentage of total cell number, estimated
tagged connecting segment mutant or wild-type 4 integrin, or mutant IBby counting the number of nuclei visualized by DAPI staining (200–400 cells).
(P. Khavari, Stanford; Seitz et al., 2000), or untagged wild-type or mutant 4
integrin retroviral supernatant. Vector controls were prepared by transfectingInduction and analysis of apoptosis
with plasmid 3.1 pcDNA, or GFP, RFP, or empty retroviral vector. ResistantApoptosis was initiated by direct receptor trimerization using the FAS recep-
4 integrin or vector control cells were selected using G418 (plasmid) ortor antibody IgM Ch-11 (1–2 g/ml); by receptor ligation with CD95 (1–2
blasticidin (retrovirus), whereas experiments conducted using the IB mu-g/ml) followed by secondary mAb-induced clustering; and by treatment
tant were done using nonselected pooled cell populations.with recombinant, purified Trail (Apo2L, 1–4g/ml; BioMol Research Labora-
tories Inc.), recombinant TNF- (10–100 nM; R&D Systems Inc.), the topo-
Flow cytometryisomerase II inhibitor, etoposide (10–100 M in DMSO; TopoGen Inc.), the
Cells grown as 2D monolayers were isolated, and nonspecific binding wasmicrotubule agent paclitaxol (20–120 nM; Sigma), the actin microfilament
blocked (60 min Dulbecco’s PBS, 1% bovine serum albumin). They weredrug cytochalasin B (1–2 g/ml; Sigma), the membrane permeable
then incubated with saturating concentrations of primary mAb and washedN-acetylsphinogine analog C2-ceramide (0.5–5 M; BioMol), or the mem-
three times and labeled with fluorescein isothiocyanate (FITC)-conjugatedbrane-permeable nonactive N-acetylsphinogine analog C2-dihydroxcera-
goat immunoglobulin. Stained cells were washed three times and immedi-mide (0.5–5 M; BioMol). Screening assays for apoptosis included Live/
ately analyzed on a FACScan (Becton Dickinson).Dead Assay (Molecular Probes), active caspase 3 detection and cleavage
of PARP by immunoblot analysis, and increased expression of annexin V in
Immunoblot analysistreated cells (Pharmingen). After initial screening, routine assay for apoptosis
To assess total 4 integrin levels, pooled populations of 4 integrin andin intact fixed cells or cryosections used a commercially available in situ
vector control transfected or infected pooled cell populations were lysed inapoptosis kit (Boehringer Mannheim). The apoptotic labeling index was cal-
RIPA buffer (50 mM Tris-HCl [pH 7.4], 150 mM sodium chloride, 1% NP-40,culated as cells positive for FITC-labeled 3	OH DNA ends as a percentage
0.5% deoxycholate, 0.2% SDS containing 20 mM sodium fluoride, and 1 mMof the total number of cells scored (200–400 cells). In some experiments,
cell death by apoptosis was confirmed by showing that DNA cleavage could sodium orthovanadate, and a cocktail of protease inhibitors). Equal amounts
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and radiotherapy modulated by the three-dimensional architecture of solidof protein were separated on nonreducing SDS-PAGE gels, immunoblotted,
tumors and spheroids. Methods Cell Biol. 64, 211–233.and detected with an ECL system (Amersham Pharmacia BioTech).
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